The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis

Fangshen Xu,Siyao Zhang,Danni Ye,Zheng Chen,Jiawei Ding,Tao Zhang,Shenli Ren,Yu Zhang,Huilin Zheng,Jie Zhou,Zhenhua Hu

DOI: https://doi.org/10.1080/17474124.2023.2165489

2023-01-01

Expert Review of Gastroenterology & Hepatology

Abstract:BackgroundNASH-related liver transplants are increasing because of the obesity epidemic, but the influence of T2DM on various levels of BMI among NASH recipients is unclear.Research design and methodsWe analyzed data retrieved from SRTR on 4,515 patients. We divided patients by BMI into five groups: normal weight; overweight; class 1 obesity; class 2 obesity; and class 3 obesity. Statistical analysis was done.ResultsPatients in the NASH group with T2DM had a lower patient and graft survival than patients without T2DM (5-year patient and graft survival: 77.5% vs. 79.8%; P = 0.001 and 76.4% vs. 78.2%; P = 0.002, respectively). Multivariate Cox proportional regression showed an independent association between T2DM and decreased patient and graft survival (HR, 1.170; P = 0.015 and HR, 1.133; P = 0.048, respectively). In the lean and the class 3 obesity NASH groups, patients with T2DM had lower patient and graft survival than the patients without T2DM. In the class 3 obesity NASH group, T2DM was independently associated with decreased patient survival (HR, 1.581; P = 0.027).ConclusionOur research reveals that the focus of the post-transplantation treatment should be different for different BMI patients.